Apple Converting to feature water-based gravure printing at Pharmapack North America

Apple Converting joins the Pharmapack North America show June 9-10 in New York at the Jacob K. Javits Convention Center. It will highlight its specialized printing, laminating, and converting capabilities and services that will be used for traditional drug-delivery systems.

Apple Converting will be located at booth 4120.

Eric Kusche, director of sales and marketing, tells PMP News there will be two primary categories to its exhibit: the high-barrier pouch stock used to secure the actual drug-delivery patch, and the customized backing film used to carry the specific medicine to the patient. 

“We are excited about being able to exhibit in 2015,” he says.

Apple Converting’s water-based gravure will be on display, an “exceptional feature” Kusche says they bring to the pharmaceutical packaging market. The company runs the gravure with its Cerutti 9-Color, 47-inch Gravure Press. It provides a wider format for superior printing and coating at high speeds, according to Apple Converting. Additionally, it has a full width vision system with defect detection and color monitoring installed.

“Apple will be featuring its ability to provide high-quality detailed printing and precision slitting that maintain tight tolerances to drug originators and generic providers,” he says. “We utilize both gravure and flexo printing technologies that incorporate either water-based or solvent-based ink systems to satisfy market requirements. The ink systems we use meet CFR requirements for direct and indirect contact.”

Kusche says the majority of Apple Converting’s competitors only provide wide web print solutions during the lamination of the pouch stocks, while Apple brings both wide and narrow web print.

“Both the size and scale of wide-web gravure printing plus lamination does not allow for the economics of smaller batch sizes that fit the pharma market with multiple SKUs,” he says. “We know and understand how to print on pre-laminated roll stock in a variety of formats.”

Apple Converting provides Flexographic and Rotogravure printing technologies to various markets, Kusche says. In addition to the transdermal and pharmaceutical industry, it offers similar printing solutions to medical device, confectionery, dairy, and industrial markets.

“The applications are always unique and we love it that way,” Kusche says. “Apple Converting’s engineering and design team has the ability to customize packaging solutions that are as unique as the application itself.”

The company has operated for more than 35 years in taking a concept from design stage to the commercial stage “without the need for exhaustive layers and red tape” seen in larger businesses, he says.

“Our heightened awareness and attentiveness to customer needs helps bring products to market faster,” Kusche says. “We are a true partner for research and development, pharm tech, or procurement groups.”

For more company information, visit http://www.appleconverting.com/index.html.